By Will Boggs, MD NEW YORK (Reuters Health) – Temsirolimus does not improve progression-free survival in metastatic renal cell carcinoma (RCC) compared to standard treatment, according to results…
NEW YORK (Reuters Health) – In patients with potentially resectable colorectal liver metastases, the use of combined PET and CT imaging (PET-CT) identifies those with occult extrahepatic disease…
Recent Videos in Reuters Health • The Doctor’s Channel Newscast Page 94
NEW YORK (Reuters Health) – After catheter ablation, patients with obstructive sleep apnea (OSA) are more likely to experience recurrence of atrial fibrillation (AF) than are their OSA-free…
NEW YORK (Reuters Health) – Diabetes incidence falls during rosiglitazone treatment but returns to baseline after rosiglitazone withdrawal, according to the preprint version of a study that is…
NEW YORK (Reuters Health) – Clinicians faced with a case of shoulder dystocia during childbirth should consider delivering the posterior shoulder after they’ve tried the two primary accepted…
NEW YORK (Reuters Health) – For the treatment of ovarian endometriomas, laser vaporization is associated with earlier recurrences and more recurrences compared with laparoscopic cystectomy, although the differences…
NEW YORK (Reuters Health) – Patients with type 2 diabetes without retinopathy can be safely screened for sight-threatening vision problems every 3 years instead of every 1 or…
NEW YORK (Reuters Health) – Very small breast tumors that generate extensive lymph node involvement may be more biologically aggressive than larger tumors with the same degree of…
NEW YORK (Reuters Health) – Children under 6 years of age who unwittingly ingest a sulfonylurea may not exhibit symptoms of hypoglycemia for up to 18 hours if…
NEW YORK (Reuters Health) – For patients with idiopathic sudden sensorineural hearing loss, intratympanic injection of corticosteroids is no better or worse than oral corticosteroid therapy, but is…
NEW YORK (Reuters Health) – The use of inhaled anticholinergic drugs to treat chronic obstructive pulmonary disease (COPD) is associated with an increased risk of developing urinary retention…
NEW YORK (Reuters Health) – Results of a meta-analysis confirm that the oral tyrosine kinase inhibitor gefitinib is effective as first-line therapy in patients with advanced non-small-cell lung…
